search
Back to results

Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses (HNP)

Primary Purpose

Depressive Disorder, Anxiety Disorders

Status
Completed
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
Mindfulness-based stress management program
Omega-3 fatty acids pills
Psychoeducation leaflet
Placebo pills
Sponsored by
National Center of Neurology and Psychiatry, Japan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Depressive Disorder

Eligibility Criteria

20 Years - 59 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Work for inpatient wards in among four general hospitals in Tama region, Japan, including: National Center of Neurology and Psychiatry Hospital, National Disaster Medical Center, Tokyo Metropolitan Tama Medical Center, and Tama-Hokubu Medical Center
  • Nurses without administration work
  • Give written consent in the participation of the study

Exclusion Criteria:

  • Have plans to take sick leave, leave for other reasons or retirement within 26 weeks from the entry to the study
  • Take structured psychotherapy (e.g. cognitive behavioral therapy, interpersonal therapy, and brief psychodynamic therapy) at the entry
  • See a physician regularly in order to treat any mood or anxiety disorders primarily at the entry
  • Take antidepressants, mood stabilizers, anticonvulsants or antipsychotics at the entry
  • Have taken nutrient supplement including omega-3 fatty acids for 4 or more weeks within 52 weeks from the entry
  • Clinically depressed, based on the total score of 11 or more on the Hospital Anxiety and Depression Scale - Depression Subscale and the total score of 15 or more on the Primary Health Care Questionnaire
  • Consume 4 times or more of fish as the main course of meal per week
  • Take anticoagulant drugs at the entry or have previous history of stroke or myocardial infarction
  • Judged ineligible by research coordinator due to any reason

Sites / Locations

  • National Center of Neurology and Psychiatry
  • Kyoto University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Active Comparator

Active Comparator

Active Comparator

Arm Label

Stress management plus omega-3

Stress management plus placebo

Psychoeducation leaflet plus omega-3

Psychoeducation leaflet plus placebo

Arm Description

Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.

Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.

Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.

Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.

Outcomes

Primary Outcome Measures

Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)
The total score of the HADS (HADS-T) ranges from 0 to 42, with higher scores indicating more symptoms. The HADS has two sub scores, each ranging from 0 to 21: HADS-D (depression) and HADS-A (anxiety). The total score will be used as the severity of depression and anxiety symptoms in the present study.

Secondary Outcome Measures

Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)
Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)
Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)
Major depressive episode will be ascertained using the Primary Care Evaluation of Mental Disorders (PRIME-MD) algorithm with the depression module of the Patient Health Questionnaire (PHQ-9). The PHQ-9 was developed as a self-report version of the PRIME-MD which aims at Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) diagnosis of several common mental disorders.
Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)
Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)
Depression severity: Personal Health Questionnaire-9 (PHQ-9)
Personal Health Questionnaire-9 is a 9-item structured questionnaire to measure depression severity.
Depression severity: Personal Health Questionnaire-9 (PHQ-9)
Depression severity: Personal Health Questionnaire-9 (PHQ-9)
Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)
The GAD-7 consists of 7 items, and the total score ranges from 0 to 21.
Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)
Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)
Insomnia severity: Insomnia Severity Index (ISI)
The ISI is now considered a standard measure of the global severity of insomnia and used in many studies. The total score between 8-14 indicates subthreshold insomnia; and 15-28, clinical insomnia. The total score of the ISI will be used as the severity of insomnia in the study.
Insomnia severity: Insomnia Severity Index (ISI)
Insomnia severity: Insomnia Severity Index (ISI)
Somatic symptoms: The Bradford Somatic Inventory (BSI)
The BSI is a 44-item questionnaire for females about symptoms experienced in the previous month, which was designed to detect physical symptoms commonly related to depressed patients.
Somatic symptoms: The Bradford Somatic Inventory (BSI)
Somatic symptoms: The Bradford Somatic Inventory (BSI)
Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)
The HPQ is a self-report instrument designed to estimate the workplace costs of health problems in terms of self-reported reduced job performance (presenteeism).
Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)
Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)
Burnout: Maslach Burnout Inventory (MBI)
The MBI is a self-report measure with 22 items and is calculated into three sub-domains such as emotional exhaustion, depersonalization and personal accomplishment.
Burnout: Maslach Burnout Inventory (MBI)
Burnout: Maslach Burnout Inventory (MBI)
Quality of Life: EuroQol (EQ-5D)
EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.
Quality of Life: EuroQol (EQ-5D)
EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.
Quality of Life: EuroQol (EQ-5D)
EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.

Full Information

First Posted
May 27, 2014
Last Updated
August 20, 2018
Sponsor
National Center of Neurology and Psychiatry, Japan
search

1. Study Identification

Unique Protocol Identification Number
NCT02151162
Brief Title
Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses
Acronym
HNP
Official Title
Mindfulness-Based Stress Management Program and Omega-3 Fatty Acids to Maintain Healthy Mental State in Hospital Nurses: Multi-Center Factorial-Design Randomized Controlled Trial Happy Nurse Project
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
June 11, 2014 (Actual)
Primary Completion Date
March 2, 2016 (Actual)
Study Completion Date
September 6, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Center of Neurology and Psychiatry, Japan

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study is to explore the effectiveness of omega-3 fatty acids and mindfulness-based stress management program to maintain healthy mental state in hospital nurses. The participants will be junior nurses who work in inpatient wards and are not clinically depressed. The participants will be randomly allocated to four intervention arms: 1) Mindfulness-based stress management program plus omega-3 fatty acids pills ; 2) Mindfulness-based stress management program plus placebo pills; 3) Psychoeducation leaflet plus omega-3 fatty acids pills; and 4) Psychoeducation leaflet plus placebo pills. Thirty participants will be allocated to each arm. These interventions will terminate until three months from registration for each participant. Information about depression and anxiety symptoms (primary outcome), insomnia, burnout, presenteeism, quality of life, sick leave, consultation about mental state of herself, and oxidative stress will be collected at 3 months, 6 months (primary time point) and 12 months from registration for each participant.
Detailed Description
The study is to explore the effectiveness of omega-3 fatty acids and mindfulness-based stress management program to maintain healthy mental state in hospital nurses. The participants will be junior nurses who work in inpatient wards at four general hospitals in Tama region in Tokyo, and are not clinically depressed based on the score of the Hospital Anxiety and Depression scale. The participants will be randomly allocated to four intervention arms: 1) Mindfulness-based stress management program plus omega-3 fatty acids pills; 2) Mindfulness-based stress management program plus placebo pills; 3) Psychoeducation leaflet plus omega-3 fatty acids pills; and 4) Psychoeducation leaflet plus placebo pills. Thirty participants will be allocated to each arm. These interventions will terminate until 3 months from registration for each participant. Stress management program will be conducted by senior nurses in four individual sessions within these three months. Psychoeducation leaflet will include information about screening of stress, sleep hygiene, relaxation, and a list of consultants about mental health. Information about depression and anxiety symptoms (primary outcome), insomnia, burnout, presenteeism, quality of life, numbers of incident and accident at work, sick leave and consultation about mental state of herself, concentration of fatty acids in serum and oxidative stress will be collected at 3 months, 6 months (primary time point) and 12 months from registration for each participant. The primary outcome will be assessed by blind raters through telephone. The outcomes will be compared between arms including stress management program and those without, and between arms including omega-3 fatty acids and those without, by using mixed model repeated measures model.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depressive Disorder, Anxiety Disorders

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Stress management plus omega-3
Arm Type
Experimental
Arm Description
Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.
Arm Title
Stress management plus placebo
Arm Type
Active Comparator
Arm Description
Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.
Arm Title
Psychoeducation leaflet plus omega-3
Arm Type
Active Comparator
Arm Description
Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.
Arm Title
Psychoeducation leaflet plus placebo
Arm Type
Active Comparator
Arm Description
Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness-based stress management program
Intervention Description
Mindfulness-based stress management program will be conducted by senior nurses in four individual sessions within these three months. Senior nurses have taken a 7-hour workshop including lectures and role-playing sessions. The detailed manual and videos including lectures will be provided to the senior nurses.
Intervention Type
Dietary Supplement
Intervention Name(s)
Omega-3 fatty acids pills
Intervention Description
Omega-3 fatty acids pills will include 1200 mg of eicosapentaenoic acid and 600 mg of docosahexaenoic acid per day.
Intervention Type
Behavioral
Intervention Name(s)
Psychoeducation leaflet
Intervention Description
Psychoeducation leaflet will include information about screening of stress, sleep hygiene, relaxation, and a list of consultants about mental health.
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo pills
Intervention Description
Placebo pills will include rapeseed oil, soybean oil, olive oil and fish oil.
Primary Outcome Measure Information:
Title
Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)
Description
The total score of the HADS (HADS-T) ranges from 0 to 42, with higher scores indicating more symptoms. The HADS has two sub scores, each ranging from 0 to 21: HADS-D (depression) and HADS-A (anxiety). The total score will be used as the severity of depression and anxiety symptoms in the present study.
Time Frame
26 weeks
Secondary Outcome Measure Information:
Title
Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)
Time Frame
13 weeks
Title
Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)
Time Frame
52 weeks
Title
Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)
Description
Major depressive episode will be ascertained using the Primary Care Evaluation of Mental Disorders (PRIME-MD) algorithm with the depression module of the Patient Health Questionnaire (PHQ-9). The PHQ-9 was developed as a self-report version of the PRIME-MD which aims at Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) diagnosis of several common mental disorders.
Time Frame
26 weeks
Title
Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)
Time Frame
13 weeks
Title
Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)
Time Frame
52 weeks
Title
Depression severity: Personal Health Questionnaire-9 (PHQ-9)
Description
Personal Health Questionnaire-9 is a 9-item structured questionnaire to measure depression severity.
Time Frame
26 weeks
Title
Depression severity: Personal Health Questionnaire-9 (PHQ-9)
Time Frame
13 weeks
Title
Depression severity: Personal Health Questionnaire-9 (PHQ-9)
Time Frame
52 weeks
Title
Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)
Description
The GAD-7 consists of 7 items, and the total score ranges from 0 to 21.
Time Frame
26 weeks
Title
Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)
Time Frame
13 weeks
Title
Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)
Time Frame
52 weeks
Title
Insomnia severity: Insomnia Severity Index (ISI)
Description
The ISI is now considered a standard measure of the global severity of insomnia and used in many studies. The total score between 8-14 indicates subthreshold insomnia; and 15-28, clinical insomnia. The total score of the ISI will be used as the severity of insomnia in the study.
Time Frame
26 weeks
Title
Insomnia severity: Insomnia Severity Index (ISI)
Time Frame
13 weeks
Title
Insomnia severity: Insomnia Severity Index (ISI)
Time Frame
52 weeks
Title
Somatic symptoms: The Bradford Somatic Inventory (BSI)
Description
The BSI is a 44-item questionnaire for females about symptoms experienced in the previous month, which was designed to detect physical symptoms commonly related to depressed patients.
Time Frame
26 weeks
Title
Somatic symptoms: The Bradford Somatic Inventory (BSI)
Time Frame
13 weeks
Title
Somatic symptoms: The Bradford Somatic Inventory (BSI)
Time Frame
52 weeks
Title
Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)
Description
The HPQ is a self-report instrument designed to estimate the workplace costs of health problems in terms of self-reported reduced job performance (presenteeism).
Time Frame
26 weeks
Title
Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)
Time Frame
13 weeks
Title
Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)
Time Frame
52 weeks
Title
Burnout: Maslach Burnout Inventory (MBI)
Description
The MBI is a self-report measure with 22 items and is calculated into three sub-domains such as emotional exhaustion, depersonalization and personal accomplishment.
Time Frame
26 weeks
Title
Burnout: Maslach Burnout Inventory (MBI)
Time Frame
13 weeks
Title
Burnout: Maslach Burnout Inventory (MBI)
Time Frame
52 weeks
Title
Quality of Life: EuroQol (EQ-5D)
Description
EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.
Time Frame
26 weeks
Title
Quality of Life: EuroQol (EQ-5D)
Description
EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.
Time Frame
13 weeks
Title
Quality of Life: EuroQol (EQ-5D)
Description
EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.
Time Frame
52 weeks
Other Pre-specified Outcome Measures:
Title
Adverse events
Description
Information about any possible adverse events will be collected during the intervention period.
Time Frame
13 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Work for inpatient wards in among four general hospitals in Tama region, Japan, including: National Center of Neurology and Psychiatry Hospital, National Disaster Medical Center, Tokyo Metropolitan Tama Medical Center, and Tama-Hokubu Medical Center Nurses without administration work Give written consent in the participation of the study Exclusion Criteria: Have plans to take sick leave, leave for other reasons or retirement within 26 weeks from the entry to the study Take structured psychotherapy (e.g. cognitive behavioral therapy, interpersonal therapy, and brief psychodynamic therapy) at the entry See a physician regularly in order to treat any mood or anxiety disorders primarily at the entry Take antidepressants, mood stabilizers, anticonvulsants or antipsychotics at the entry Have taken nutrient supplement including omega-3 fatty acids for 4 or more weeks within 52 weeks from the entry Clinically depressed, based on the total score of 11 or more on the Hospital Anxiety and Depression Scale - Depression Subscale and the total score of 15 or more on the Primary Health Care Questionnaire Consume 4 times or more of fish as the main course of meal per week Take anticoagulant drugs at the entry or have previous history of stroke or myocardial infarction Judged ineligible by research coordinator due to any reason
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Norio Watanabe, MD, PhD
Organizational Affiliation
Kyoto University
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Center of Neurology and Psychiatry
City
Kodaira
State/Province
Tokyo
ZIP/Postal Code
187-8551
Country
Japan
Facility Name
Kyoto University
City
Kyoto
ZIP/Postal Code
606-8501
Country
Japan

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
32627860
Citation
Kunzler AM, Helmreich I, Chmitorz A, Konig J, Binder H, Wessa M, Lieb K. Psychological interventions to foster resilience in healthcare professionals. Cochrane Database Syst Rev. 2020 Jul 5;7(7):CD012527. doi: 10.1002/14651858.CD012527.pub2.
Results Reference
derived
PubMed Identifier
30927579
Citation
Watanabe N, Horikoshi M, Shinmei I, Oe Y, Narisawa T, Kumachi M, Matsuoka Y, Hamazaki K, Furukawa TA. Brief mindfulness-based stress management program for a better mental state in working populations - Happy Nurse Project: A randomized controlled trial✰✰. J Affect Disord. 2019 May 15;251:186-194. doi: 10.1016/j.jad.2019.03.067. Epub 2019 Mar 22.
Results Reference
derived
PubMed Identifier
25636180
Citation
Watanabe N, Furukawa TA, Horikoshi M, Katsuki F, Narisawa T, Kumachi M, Oe Y, Shinmei I, Noguchi H, Hamazaki K, Matsuoka Y. A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses (Happy Nurse Project): study protocol for a randomized controlled trial. Trials. 2015 Jan 31;16:36. doi: 10.1186/s13063-015-0554-z.
Results Reference
derived

Learn more about this trial

Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses

We'll reach out to this number within 24 hrs